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UP IN SMOKE:
THE MEDICINAL MARIJUANA DEBATE
I. INTRODUCTION
"The marijuana, cannabis or hemp plant is one of the oldest psycho-
active plants known to humanity."' It grows as a weed, is cultivated all
over the world and is one of the most widely diversified plants. 2 The
first recorded use of marijuana is found in the Herbal, written between
400 and 500 B.C.3 Even at that time, some felt that marijuana was evil,
while others felt that it would lead them to a utopia.4
Today, marijuana is a subject of intense social, political, legal and
medical controversy concerning how dangerous or safe it is. 5 The
drug's opponents view marijuana "as an addicting drug that leads to
personality deterioration and psychoses and to criminal behavior and
sexual excess." 6 In fact, seventy-five percent of criminal offenders in
the United States believe they were under the influence of marijuana at
the time they committed the crime, and seven percent of homicides are
believed to be directly related to the use of marijuana.7 Its proponents,
on the other hand, assert that marijuana is no more harmful than aspirin
and therefore should be equally available. 8 The current trend in the
marijuana controversy, as seen in recent legislative enactments in both
California and Arizona, is legalization of marijuana for medical uses. 9
1. See LESTER GRINSPOON & J AMES B. B AKALAR, MARUUANA T HE FORBIDDEN MEDICINE 1 (1993).
Marijuana is classified as a member of the family Cannabaceae and the genus Cannabis. See id.
2. See id. The fiber of the plant has been used for cloth and paper for centuries. See id. It was
also the most important source of rope until the development of synthetic fibers. See id. The seeds of
the plant have been used as bird feed and, sometimes, as human food. See id. The oil contained in the
seeds was once used for lighting and soap and is now sometimes used in the manufacture of varnish,
linoleum and artist's paints. See id.
3. See LESTER G RINSPOON, MARUUANARECONSIDERED I (1994). The Herbal is equivalent to the
U.S. Pharmacopeia, a book containing a list of drugs, their formulas and the methods of making
medicinal preparations. See id.
4. See id. The euphoria felt after using marijuana was frightening to some, and others believed it
caused people to do evil things. See id. Members of an ancient Chinese-Persian religious cult used
marijuana to enable them to conduct suicide missions of political murder. See GRAY J. M ILLER, DRUGS
AND THE LAW: DETECTION, RECOGNITION & INVESTIGATION 393 (1992). Other individuals enjoyed the
euphoric feeling because it gave them confidence to do things that may improve life. See GRINSPOON,
supra note 3, at 1.
5. See GRINSPOON, supra note 3, at I.
6. See GRINSPOON, supra note 3. at I.
7. See Abbie Crites-Leoni, Note, Medical Uses of Marijuana: Is the Debate a Smoke Screen for
Movement Toward Legalization?, 19 J. LEGAL MED. 273, 273-74 (1998) (citing Testimony to the United
States House of Representatives Crime Subcommittee (Mar. 6, 1996) (statement of Eric A. Voth)).
8. See GRINSPOON, supra note 3, at 2.
9. See Crites-Leoni, supra note 7, at 274. On November 3. 1998, Alaska, Colorado, Nevada, Ore-
gon, Washington and the District of Columbia voted to legalize some medicinal use of marijuana, bring-
ing the total number of states which have passed medicinal marijuana laws to eight. Normal, (last
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These enactments are substantial stepping stones for the legalization of
the drug.IO
This Note discusses the legalization of marijuana for medical use.
This Note does not take a position for or against the use of marijuana for
medical purposes. Rather, it outlines both sides of the issue. Based on
this discussion, this Note concludes that legalization of the drug is
premature.
Part I reviews the history of marijuana.11 Part II outlines the use
of marijuana for medicinal purposes, including its benefits and
detriments.1 2 Part III analyzes the direction of the courts in the debate
over the medical necessity of marijuana. 13 Finally, Part IV discusses the
movement toward legalization of marijuana, including an analysis of
North Dakota's law and position in this area.14 The Conclusion cautions
against full-scale legalization of marijuana for medical purposes but
urges expansion of courts' power to accept the medical necessity
defense to drug prosecutors.
II. THE HISTORY OF MARIJUANA
Marijuana has been a popular drug for medical treatment since
ancient times.15 The first known recording of its medicinal effect was in
the Chinese pharmacopoeia Rh-Ya in the fifteenth century. 16  According
to the Rh-Ya, marijuana was used to remedy pain, rheumatism and severe
menstrual cramps.1 7 Indians, Africans, ancient Greeks and medieval
Europeans also used marijuana to treat fevers, dysentery and malaria.18
visited Feb. 2, 1999) <http://www. norml.org/news/archives/98-11-04.shtml>.
10. See id.
11. See generally GRINSPOON & B AKALAR, supra note 1; GRINSPOON, supra note 3; MILLER, supra
note 4; Crites-Leoni, supra note 7.
12. See generally GRiNspooN & BAKALAR, supra note 1; Gregg A. Bilz, Note, The Medical Use of
Marijuana: The Politics of Medicine, 13 HAmLnE J. PUB. L. & POL'Y 117 (1992); Matthew W. Grey,
Note, Medical Use of Marijuana: Legal and Ethical Conflicts in the Patient/Physician Relationship, 30
U. RICH. L. REV. 249 (1996). See also 57 Fed. Reg. 10,499 (1992).
13. See generally United States v. Randall, 104 Daily Wash. L. Rtpr. 2249 (D.C. Super. Ct. 1976);
Jenks v. State, 582 So. 2d 676 (Fla. Dist. Ct. App. 1991); State v. Hanson, 468 N.W.2d 77 (Minn. Ct.
App. 1991); State v. Tate, 505 A.2d 941 (N.J. 1986); Seeley v. State, 940 P.2d 604 (Wash. 1997).
14. See generally Alliance v. Cannabis Therapeutics v. Drug Enforcement Ass'n, 930 F.2d 936
(D.C. Cir. 1991); NORML v. Drug Enforcement Ass'n, 559 F.2d 735 (D.C. Cir. 1977); NORML v.
Ingersoll, 497 F.2d 654 (D.C. Cir. 1974).
15. See Crites-Leoni, supra note 7, at 274. The chemical compounds responsible for marijuana's
intoxicating and medicinal effects are found mainly in a sticky golden resin secreted from the flowers
on the female plants. See GRINSPOON & B AKALAR, supra note 1, at 2. "The function of the resin is
thought to be protection from heat and preservation of moisture during reproduction. The plants
highest in resin therefore grow in hot regions like Mexico, the Middle East and India." See GRnspooN
& BAKALAR, supra note 1, at 2.
16. See Crites-Leoni, supra note 7, at 274.
17. See Crites-Leoni, supra note 7, at 274.
18. See Grey, supra note 12, at 251. Another Chinese writing recommended a mixture of hemp
resin and wine as an anaesthetic during surgery. See GaiNsroON & B AKALAR, supra note 1, at 3. Simi-
larly, in India, cannabis was recommended to quicken the mind, lower fevers, induce sleep, cure
dysentery, stimulate appetite, improve digestion, relieve headaches and cure venereal disease. See id.
556 [VOL. 75:555
As useful as the drug was for medical purposes in ancient times, it did
not make its way into the West until the middle of the nineteenth
century. 19
European settlers first brought marijuana to the United States in
1611.20 Colonists used the fiber of the plant to produce clothing, twine,
rope, paper, blankets and canvas. 21 Marijuana was so important to the
colonists that the government imposed a penalty on those who did not
cultivate it.22 After the Civil War, cultivating marijuana for fiber lost its
importance, 23 due mainly to the development of the cotton gin and other
cotton and wool machinery, as well as competition from cheap imported
hemp. 24 However, other uses of marijuana were just beginning to
emerge. 25
As early as 1840, Americans used marijuana as a medicine; it was
included in the United States Pharmacopoeia as a way to treat numerous
symptoms. 26 By 1890, the medical use of the drug declined, due in
large part to the development of more reliable synthetic drugs such as
aspirin, chloral hydrate and barbiturates.2 7 The practice of smoking
marijuana for recreational purposes most likely began when the
Eighteenth Amendment of the United States Constitution 28 had the effect
of raising the price of alcoholic beverages and making alcohol less
convenient to secure.2 9 By the 1930s, the legalization of beer and the
In England, Robert Burton, an English clergyman, suggested in the 1621 Anatomy of Melancholy, that
marijuana be used for the treatment of depression. See GRINSPOON & BAKALAR, supra note 1, at 3. The
New English Dispensatory of 1764 recommended that the roots of the plant be applied to skin to treat
inflammation. SeeGRINSPOON & BAKALAR, supra note 1, at 11. Finally, the Edinburgh New
Dispensatory of 1794 included a long description of the effects of marijuana and stated that its oil was
useful in the treatment of coughs, venereal disease and urinary incontinence. See GRINSPOON &
BAKALAR, supra note 1. at 3.
19. See GRiNSPooN & BAKALAR, supra note 1, at 4.
20. See NATIONAL GOVERNORS' CONFERENCE CENTER FOR POLICY RESEARCH AND ANALYSIS,
MARUUANA: A STUDY OF STATE POLICIES & PENALTIES 1(1977).
21. See id. During and after the Revolution, American settlers continued to grow hemp, chiefly
in the area of what became Kentucky. See GRINSPOON & B AKALAR, supra note 1, at 11. Hemp farming
became a respectable, often familial occupation. See GRINSPOON & BAKALAR, supra note 1, at 11.
22. See GRINS'OON & BAKALAR, supra note 1, at 11.
23. See MILLER, supra note 4 at 394.
24. See MILLER, supra note 4, at 394.
25. See MILLER, supra note 4, at 394.
26. See Bilz, supra note 12, at 118. Such symptoms include tetanus, dysmenorrhea (painful men-
struation), convulsions, rheumatic and child birth pain, asthma, post partum psychosis, gonorrhea,
chronic bronchitis and headaches. The Pharmacopeia also recommended using marijuana to induce
sleep and stimulate the appetite. See GRINSPOON & BAKALAR, supra note 1, at 5.
27. See GRINSPOON & BAKALAR, supra note 1, at 7.
28. The 18th Amendment of the United States Constitution states: "[Aifter one year from the
ratification of this article the manufacture, sale, or transportation of intoxicating liquors within, the
importation thereof into, or the exportation thereof from the United States and all territory subject to
the jurisdiction thereof for beverage purposes is hereby prohibited." U.S. CONST. amend. XVIII, § 1.
29. See MILLER supra note 4, at 394. There is evidence that during this time marijuana "tea
pads" were established. See MILLER, supra note 4, at 394. These pads were like opium dens and
allowed people to get high on marijuana for a quarter. See MILLER, supra note 4, at 394.
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return of hard liquor decreased the popularity of marijuana. 30 However,
the most important reason for the decline of marijuana as a recreational
drug was legal intervention. 31
On January 1, 1932, the Federal Bureau of Narcotics 32 warned that
marijuana had come into widespread and increasing abuse and encour-
aged the passage of rigid marijuana laws.33 By 1937, nearly every state
had laws restricting marijuana. 34 Under most of these laws, use of
marijuana was subjected to the same penalties applicable to morphine,
heroin, and cocaine, even though designating marijuana as a narcotic was
technically incorrect. 35
On the federal level, the Marijuana Tax Act of 193736 prohibited
the use of marijuana as an intoxicant and restricted its use as a medi-
cine. 37 This Act allowed the government to make obtaining the drug
legally for anything other than medical purposes prohibitively expen-
sive. 38 It also made medical use of marijuana difficult because of the
extensive paperwork required of doctors who prescribed it.39 The
Federal Bureau of Narcotics took advantage of the lack of use by phy-
30. See MILLER, supra note 4, at 395.
31. See MILLER, supra note 4, at 395.
32. The Federal Bureau of Narcotics, formed in 1930, developed from the Treasury Depart-
ment's Bureau of Prohibition and was charged with the enforcement of federal laws pertaining to
narcotics. See MILLER supra note 4, at 462.
33. See MILLER, supra note 4, at 395.
34. See MILLER, supra note 4, at 395. In 1935, the Commissioner of Narcotics, Harry J. An-
slinger, sent the following message to the states:
The states and cities should rightfully assume the responsibility for providing vigorous
measures for the extinction of this lethal weed, and it is therefore hoped that all public-
spirited citizens will earnestly enlist in the movement urged by the Treasury Department
to adjure intensified enforcement of marijuana laws.
MILLER, supra note 4, at 395. As a result, 46 of the 48 states as well as the District of Columbia had
laws against marijuana by 1937. See MILLER, supra note 4, at 395.
35. See MILLER, supra note 4, at 395. The word "narcotics" refers to substances which relieve
pain and produce sleep. See MILLER, supra note 4, at 395. They are the most valuable drugs available
to physicians and are widely used to relieve short-term acute pain, reduce suffering in terminal
illnesses, and promote rest so the body can restore itself. See MILLER, supra note 4, at 395. However,
they can cause either physical addiction, psychological addiction or both, and so their use is controlled.
See MILLER, supra note 4, at 395.
36. See Marijuana Tax Act, Pub. L. No. 75-238, ch. 553, 50 Stat. 551 (1937). The Marijuana
Tax Act of 1937 fully recognized the medicinal uses of the substances. See id. The Act specified that
physicians, dentists, veterinarians and others could continue to prescribe cannabis if they paid a
license fee of one dollar per year; that druggists who dispensed the drug should pay a license fee of
$15 a year; that growers of marijuana should pay $25 a year; and that importers, manufacturers and
compounds should pay $50 a year. See id. At the time of the Act, only the nonmedicinal, untaxed
possession or sale of marijuana was outlawed. See id.
37. See id.
38. See GRINSPOON & BAKALAR, supra note 1, at 8.
39. See GRINSPOON & BAKALAR, supra note i, at 8.
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sicians and removed marijuana from the United States Pharmacopeia4O
in 1941.41
Since the Marijuana Tax Act, restrictions on marijuana have in-
creased in quantity and severity. 42 Laws began to specify that marijuana
penalties should be the same as those for heroin, meaning marijuana
penalties escalated along with heroin penalties. 43 For instance, the Boggs
Act 44 of 1951 established mandatory prison terms and large fines for the
violation of any federal law, including narcotics and marijuana laws.4 5
The Narcotic Control Act of 195646 further strengthened those
penalties. 47
In 1970, Congress enacted the Controlled Substances Act; 48 it estab-
lished five schedules for controlled substances, grouping the drugs to-
gether based on their effects on the body.49 The Controlled Substances
40. The United States Pharmacopeia is a book published under the jurisdiction of the govern-
ment; it contains a list of drugs, their formulas and the methods for making medicinal preparations.
WEBSTER'S COLLEGE DICTIONARY (1992).
41. See GRINSPOON & B AKALAR, supra note 1, at 8. As stated above, the medical use of marijuana
lost its importance due to the development of more reliable synthetic drugs such as aspirin, chloral
hydrate and barbiturates. See GRINSPOON & BAKALAR, supra note I, at 7.
42. See MILLER, supra note 4, at 396.
43. See Boggs Act of 1951, Pub. L. No. 82-255, ch. 666, 65 Stat. 767 (1951). See also Narcotic
Control Act of 1956, Pub. L. No. 84-728, ch. 629, 70 Stat. 567 (1956).
44. The Boggs Act of 1951, 65 Stat. at 767. The Boggs Act for the first time imposed minimum
mandatory sentences for violations of the narcotic and marijuana laws. See H.R. REP. No. 2388
(1956). It provides a penalty of not less than two years nor more than five years for a first offense;
not less than five years nor more than 10 years for a second offense, and not less than 10 years nor
more than 20 years for a third offense. See id. The Act also prescribes a mandatory fine not to
exceed $2,000.00. See id.
45. See H.R. REP. No. 2388 (1956).
46. See Narcotic Control Act of 1956, Pub. L. No. 84-728, ch. 629, 70 Stat. 567 (1956). The
Narcotic Control Act was established to provide more effective means for the eradication of the illicit
trafficking and the illicit use of drugs. See id. The Act continued to subject violators to the minimum
mandatory sentences of the Boggs Act, but increased the maximum sentences to 10, 20, and 40 years
respectively. See H.R. REP. No 2388 (1956).
47. See Suzanne D. McGuire, Note, Medical Marijuana: State Law Undermines Federal Mari-
juana Policy---Is the Establishment Going to the Pot?, 7 SAN J. A. L. REV. 73, 74 (1997).
48. See Controlled Substances Act, 21 U.S.C. § 812 (1994).
49. Id. The five established schedules are known as schedules I, II, III, IV and V. The findings
required for each of schedules are as follows:
I) Schedule I.
A) The drug or other substance has a high potential for abuse.
B) The drug or other substance has no currently accepted medical use in treatment
in the United States.
C) There is a lack of accepted safety for use of the drug or other substance under
medical supervision.
2) Schedule II.
A) The drug or other substance has a high potential for abuse.
B) The drug or other substance has a currently accepted medical use in treatment
in the United States or a currently accepted medical use with severe restrictions.
C) Abuse of the drug or other substances may lead to severe psychological or
physical dependence.
3) Schedule Il.
A) The drug or other substance has a potential for abuse less than the drugs or other
NORTH DAKOTA LAW REVIEW [VOL. 75:555
Act unified all drugs subject to federal regulation, and subjected them to
increasing levels of control on the basis of abuse potential and lack of
therapeutic usefulness. 5 0 The Act designated marijuana as a Schedule I
drug because of its potential for abuse and because it had no currently
accepted medical value.51
In spite of this designation, marijuana today ranks among corn,
wheat and soybeans as one of the four major cash crops in the United
States; it is also one of the four most commonly used recreational drugs
in the United States. 52 Due to the controversy surrounding marijuana,
the race began to determine the medical value of the drug and its true
effect on people.5 3
substances in schedules I and II.
B) The drug or other substance has a currently accepted medical use in
treatment in the United States.
C) Abuse of the drug or other substance may lead to moderate or low physical
dependence or high psychological dependence.
4) Schedule IV.
A) The drug or other substance has a low potential for abuse relative to the
drugs or other substances in schedule Ill.
B) The drug or other substance has a currently accepted medical use in treatment
in the United States.
C) Abuse of the drug or other substance may lead to limited physical dependence
or psychological dependence relative to the drugs or other substances in
schedule III.
5) Schedule V.
A) The drug or other substance has a low potential for abuse relative to the drugs or
other substances in schedule IV.
B) The drug or other substance has a currently accepted medical use in treatment
in the United States.
C) Abuse of the drug or other substance may lead to limited physical dependence
or psychological dependence relative to the drugs or other substances in
schedule IV.
See id. There are many reasons why drugs are classified into groups. See MILLER, supra note 4, at
109. If one drug of a class is physically addicting, or is associated with severe psychotic symptoms, it
is very likely other drugs of that class will share this property. See MILLER, supra note 4, at 109. If
two drugs of the same class are taken at the same time, they are likely to boost a potentially lethal
overdose. See MILLER, supra note 4, at 109. Therefore, grouping drugs by their effects makes it
easier to remember that drugs listed under a certain classification have similar effects on the body.
See MILLER, supra note 4, at 109.
50. See MILLER, supra note 4, at 465. The Act also gave the Attorney General and Secretary of
Health, Education and Welfare the flexibility to add new drugs to the controlled substances list, to
modify the degree of regulation of drugs already classified, and to delete drugs from the list on the
basis of new evidence pertaining to abuse capacity. See MILLER, supra note 4, at 465.
51. See McGuire, supra note 47, at 74. Marijuana is presently classified in Schedule I because it
has no currently accepted medical value. See McGuire, supra note 47, at 74. To be acceptable for
medical use, a drug must be approved under federal statutory criteria in one of the following
categories: I) approved by the Food and Drug Administration (FDA) as safe and effective for use in
treatment, based on substantial scientific evidence; 2) generally recognized among experts qualified
by scientific training and experience to evaluate the safety and effectiveness, based on substantial
scientific evidence; 3) accepted for use in veterinary medicine requiring recognition among experts
qualified by scientific training and experience to evaluate its safety and effectiveness of animal drugs
based on substantial scientific evidence; and 4) accepted prior to 1938; this category requires that a
drug was approved under the Food, Drug and Cosmetic Act (FDCA), and that it retains its exact
formulation and is never promoted for new uses. See 21 U.S.C. § 321(p), (w) (1994).
52. See MILLER, supra note 4, at 397.
53. See McGuire, supra note 47, at 74.
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III. THE USE OF MARIJUANA AS MEDICINE
In our century, marijuana has been proposed or shown to be useful
as a medicine for many disorders, including cancer, 54 glaucoma, 55
AIDS,56 and multiple sclerosis. 57 Tetrahydrocannabinols, or THC, is the
main active ingredient in marijuana which potentially has medicinal
value.5 8 Proponents for the medicinal use of the drug point to the main
benefits of marijuana; it stimulates appetite, relieves nausea and can re-
duce spasticity.59 Opponents to the legalization movement claim that
presenting marijuana as a medicine is an effort to minimize marijuana's
negative effects on the American public and therefore cause society to
question the illegal status of the drug.60 These different views have made
the medicinal use of marijuana a subject of great controversy, leading to
the question of how useful or dangerous the drug is.61
A. THE BENEFITS OF THE MEDICINAL USE OF MARIJUANA
In the early 1970s, the National Organization for Reform of Mari-
juana Laws (NORML)62 began fighting to change marijuana from a
Schedule I substance to a Schedule II substance. 63  In part because of
this movement, Congress in the mid 1970s began the Compassionate
Investigative New Drug (IND)64 Program, which allowed patients to
54. See GRINSPOON & BAKALAR, supra note 1, at 24-40.
55. See GRINSPOON & BAKALAR, supra note 1, at 40-57.
56. See GRINSPOON & BAKALAR, supra note 1, at 85-91.
57. See Gwsr'ooN & BAKALAR, supra note 1, at 67-81. Proponents have suggested a variety of
other clinical uses of marijuana, such as for the treatment of asthmatics, depression, pain, alcoholism
and drug dependence. See MILLER, supra note 4, at 417. Although marijuana has not been adequately
researched to treat these disorders, there is little evidence it would prove effective for any of them.
See MILLER, supra note 4, at 417.
58. See 57 Fed. Reg. 10,499, 10,500 (1992). Scientific studies show pure THC, pharmaceutically
made in a clean capsule form called marinol, has some effect in controlling nausea and vomiting,
leading some to believe marijuana, because it contains THC, would be equally effective. See id.
However, the marijuana plant contains more than 460 known compounds, only 60 of which contain
THC. See GRuNsPooN & BAKALAR, supra note 1, at 2. The effects of the 400 other compounds are
unknown. See GRINSPOON & BAKALAR, supra note 1, at 2.
59. See Crites-Leoni, supra note 7, at 279.
60. See Crites-Leoni, supra note 7, at 280. Some of these negative effects include lung problems
such as bronchitis and emphysema, damaged brain cells, lowered blood pressure, rapid heartbeat and
heart palpitations. See 57 Fed. Reg. at 10,500.
61. See Crites-Leoni, supra note 7, at 279.
62. NORML was founded in 1970 and has been the principal national advocate for legalizing
marijuana. NORML <http://www.norml.org/about/index/shtml> (last visited Nov. 14, 1998). Today,
NORML serves as an informational resource to the national media on marijuana-related stories,
lobbies state and federal legislators to permit the medical use of marijuana and to reject recent
attempts to treat minor marijuana offenses more harshly, and serves as the umbrella group for national
networks of citizen activists committed to ending marijuana prohibition. See id.
63. See Crites-Leoni, supra note 7, at 277.
64. The program provided free, pre-rolled marijuana cigarettes to about a dozen approved
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obtain marijuana for therapeutic use from the government. 65 However,
the program was suspended in 1991 because it conflicted with the nation-
al anti-drug policy. 66 Today, nineteen states67 permit therapeutic re-
search programs and give physicians the ability to prescribe marijuana. 68
In 1967, marijuana had no known use in medical practice in most
countries of the world, including the United States.69 However, in a 1991
survey, nearly fifty percent of responding physicians said they would
prescribe the drug. 70 The Committee of the Institute of Medicine of the
National Academy of Sciences remarked in a report that cannabis is
promising in areas, but it warned that the dosage required to produce an
effect on patients is likely to produce unwanted side effects. 7 1 The
patients. See Michael Vitiello, Note, Proposition 215: Defacto Legalization of Pot and the Shortcom-
ings of Direct Democracy, 31 U. MIcH. J.L. REV. 707, 756 (1998). The program was under the control
of three separate agencies: the Federal Drug Agency (FDA) (responsible for evaluating the medical
merits of applications), the Drug Enforcement Agency (DEA) (responsible for enforcing legal pro-
cedures to secure marijuana), and the National Institute of Drug Abuse (responsible for the cultivation
of marijuana on its Mississippi farm). See id.
65. See Crites-Leoni, supra note 7, at 277.
66. See Crites-Leoni, supra note 7, at 278. The National Anti-drug Policy is a strategy which
seeks to reduce drug abuse, trafficking and their consequences. Specifically, drug abuse is to be
curbed by preventing youth from using illegal drugs, reducing the number of users and decreasing
drug availability. See Crites-Leoni, supra note 7, at 278. This is to be accomplished by education and
the enforcement of anti-drug laws. The National Anti-drug Policy (visited Nov. 14, 1998) <http://
www.health.org/ndes98/ihtml.
67. ALA. CODE §§ 20-2-110 to -120 (1997); CAL. HEAJTiH & SAFETY CODE § 11362.5 (West Supp.
1999); CONN. GEN. STAT. ANN. §§ 21a-246, -253 (West 1994); GA. CODE ANN. §§ 84-901a to 907a
(1985 & Supp. 1993); 720 ILL. COMP. STAT. ANN. 550/11 (West 1993); LA. REV. STAT. ANN. § 40:1021
(West 1992); MASS. GEN. LAWS ANN. ch. 94D, §§ 1-3 (West 1997); MINN STAT. ANN. § 152.21 (West
1998); N.H. REV. STAT. ANN. § 318-B:10 (1995 & Supp. 1998) (allowing for prescription of FDA-
approved and classified cannabis-type drugs); N.J. STAT. ANN. §§ 26:2L-1 to -9 (West 1996); N.M.
STAT. ANN. §§ 26-2A-1 to -7 (Michie 1997); N.Y. PUB. HEALTH LAW §§ 3328, 3397-a to -g (McKinney
1993); N.C. GEN STAT. § 90-101 (1997) (allowing prescription of THC drugs Dronabinol and Nabilone
only as antiemetic agents in cancer chemotherapy); R.I. GEN. LAWS §§ 21-28.4-01 to -11 (1989); S.C.
CODE ANN. § 44-53-610 (Law Co-op. 1985 & Supp. 1998); VT. STAT. ANN. tit. 18, § 4471 (1982); VA.
CODE ANN. § 18.2-251.1 (Michie 1996); WASH. REV. CODE ANN. §§ 69.51.010-.080 (West 1997 & Supp.
1999); WIS. STAT. ANN. § 961.34 (West 1998).
68. See Crites-Leoni, supra note 7, at 277.
69. See GRINSPOON, supra note 3, at 327.
70. See Bilz, supra note 12, at 117. Harvard's Kennedy School of Government anonymously sur-
veyed 1,035 oncologists about marijuana's usefulness. See MILLER, supra note 4, at 419. Forty-four
percent said they had recommended marijuana to at least one patient; 63% said marijuana was
effective; and 48% said they would prescribe it if it were legal. See MILLER, supra note 4, at 419.
71. See MARIJUANA, MEDICINE AND THE LAW: HEARING BEFORE THE U.S. DRUG ENFORCEMENT AD-
MINISTRATION 425 (R.C. Randall ed., 1988) (quoting INSTrrUTE OF MEDICINE, MARIJUANA AND HEALTH
139 (National Academy Press ed., 1982)) [hereinafter MARIJUANA].
Cannabis shows promise in some of these areas, although the dose necessary to produce
the desired effect is often close to one that produces an unacceptable frequency of toxic
side effects. What is perhaps more encouraging ... is that cannabis seems to exert its
beneficial effects through mechanisms that differ from those of other available drugs.
This raises the possibility that some patients who would not be helped by conventional
therapies could be treated with cannabis .... It may be possible to reduce side effects
by synthesizing related molecules that could have a more favorable ratio of desired to




report therefore recommended that research should focus its efforts on
finding a method to reduce the drug's unwanted side effects. 72
Cannabis derivatives have several uses in the treatment of cancer.73
Two of the most frequent side effects experienced by cancer patients
undergoing chemotherapy are nausea and vomiting. 7 4 After each
treatment, chemotherapy patients may suffer dry-heaves; these may last
for hours or even days, followed by days or weeks of nausea. 75 These
side effects lead to additional complications, including metabolic and
physiological disturbances such as severe dehydration, malnutrition and
vitamin deficiency. 76 Further, the loss of control can be emotionally
devastating, and as patients lose weight and strength it may become more
and more difficult to sustain the will to live. 77 Many patients take drugs
such as prochlorpesazin 78 or zofran79 to relieve symptoms, but these
drugs are extremely expensive and in some cases do not work.8 0
Marijuana may be an effective substitute for cancer patients who need
further relief.8 '
Glaucoma is another major illness whose victims benefit from the
use of marijuana. 82 Glaucoma, one of the leading causes of blindness, is
an ocular disease which causes an increase in intraocular pressure, damag-
72. See id.
73. See GRiNSPOON & BAKAAR, supra note 1, at 25.
74. See GRiNSPOON & BAKALAR, supra note 1, at 25.
75. See GRINSPOON & BAKALAR, supra note 1, at 25.
76. See GRInsPooN & BAKALtAR, supra note 1, at 25.
77. See Timothy E. Quill, Doctor, I Want to Die, Will You Help Me?, 270 JAMA 870 (1993)
(explaining that a patient wished to end his life after several bouts of chemotherapy because its side
effects were so severe).
78. Prochlorperzine is used to control severe nausea and vomiting. See PHYSICIANS DESK REFER-
ENCE 2806-07 (52nd ed. 1998).
79. Zofran is used to prevent nausea and vomiting associated with chemotherapy. See id. at
1177-79.
80. See GRINSPOON & BAKALAR, supra note 1, at 25-26. Zofran is considered the most effective
drug to ease the effects of chemotherapy. GRiNspOoN & B AKALAR, supra note 1, at 25-26. It must be
administered over a period of hours through an intravenous drip while the patient remains in a hospital
bed at a cost of hundreds of dollars per treatment. See GRINSPOON & BAKALAR, supra note 1, at 26.
81. See GRIrsPooN & B AKALAR, supra note 1, at 26. One cancer patient would vomit violently for
8 to 10 hours after receiving his chemotherapy injections. See MARUANA, supra note 71, at 88-90.
Then he would become so nauseous that he could not look at or smell food. See MARIJUANA, supra note
71, at 88-90. He was unable to keep down any food and lost 30 pounds in less than two months. See
MARIJUANA, supra note 71, at 88-90. This cancer patient began smoking marijuana and the vomiting
abruptly stopped. See MARIJUANA, supra note 71, at 88-90. The THC in marijuana eased the nausea
and caused an increase in appetite, allowing the patient to eat and regain lost weight. See MARJUANA,
supra note 71, at 88-90.
82. See MARJUANA, supra note 71, at 342. Glaucoma is a disorder that results from an imbalance
of pressure within the eye. See GINSPOON & BA, At.AR, supra note 1, at 40. The eyeball must be al-
most perfectly spherical to focus light accurately on the retina. See GRINSPooN & BAKALAR, supra note
1, at 40. Its shape is maintained by the pressure of an internal fluid, the aqueous humor. See GRIN-
SPOON & BAKALAR, supra note 1, at 40. If the eye produces too much of this fluid or if the channels
through which the fluid flows are blocked, the increasing pressure may damage the optic nerve, which
carries impulses from the eye to the brain. See GRINSPOON & BAKALAR, supra note 1, at 40.
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ing the optic nerve and leading to eventual loss of vision. 83 Medical treat-
ment or surgery can reduce the intraocular pressure, but although
surgery is useful in many cases, there is a high incidence of failure.8 4
Anti-glaucoma drugs are effective for regulating intraocular pressure,
but they all tend to produce side effects. 85 Research has shown that
smoking marijuana, however, leads to a fall in intraocular pressure and a
fifty percent reduction in tear flow approximately one hour after
ingestion. 86
Marijuana smoking also reduces symptoms of multiple sclerosis,87
paraplegia, 88 quadriplegia 89 and muscle spasms. 90 Although there is no
known effective treatment for the symptoms of these disabilities, mari-
juana is used to alleviate the pain associated with them.9 1 In addition,
smoking marijuana can calm the symptoms of the AIDS92 virus. 93
Generally, smoking marijuana combats the nausea and wasting
83. See GRINSPOON & BAKALAR, supra note i, at 40. Glaucoma afflicts 1.5 percent of the
population at age 50 and about five percent at age 70. See GRNSPOON & BAKALAR, supra note 1, at 40.
It is the leading cause of blindness in the United States, accounting for 10% of adult onset cases. See
GRiNSPOON & BAKALAR, supra note I, at 40.
84. See MARIJUANA, supra note 71, at 342. Surgery is especially risky in the advanced level of
damage. See GRINSPOON & BAKALAR, supra note 1, at 49. There are usually only small fragments of
healthy optic tissue before surgery is performed and the surgery will more than likely annihilate the
healthy tissue that is left. See GRINSPOON & BAKALAR, supra note 1, at 49.
85. See GRINSPOON & BAKALAR, supra note 1, at 49. Glaucoma is treated chiefly with eyedrops
containing beta blockers such as Paradoxically and Pilocarpine. See GRINSPooN & BAKALAR, supra
note 1, at 40. Some side effects include blurred visions, impaired night vision, cataracts, loss of
appetite, nausea, diarrhea, kidney stones, headaches, numbness, tingling, depression and fatigue. See
GRINsPOON & BAKALAR, supra note 1, at 41.
86. See MARIJUANA, supra note 71, at 344. In a 1971 study, the researcher noted that a fall in
intraocular pressure and tear flow occurred approximately one hour after smoking two percent
marijuana through a water-cooled pipe. See MARIJUANA, supra note 71, at 344. In another study,
researchers noted a fall in ocular tension after the administration of THC; finally, other studies have
found a correlation between the feeling of euphoria experienced from smoking marijuana and a fall in
intraocular pressure. See MARIJUANA, supra note 71, at 344.
87. Multiple sclerosis is a disorder in which patches of myelin (protective covering of nerve
fibers) in the brain and spinal cord are destroyed, and the normal functioning of the nerve fibers
themselves are interrupted. See GRINSPOON & BAKALAR, supra note I at 67-68.
88. Paraplegia is a weakness or paralysis of muscles in the lower body caused by disease and
injury in the middle or lower part of the spinal cord. See GRINSPOON & BAKALAR, supra note 1, at
67-68.
89. Quadriplegia results from a spinal cord injury near the neck, resulting in paralysis of the
muscles in the arms and legs. See GRINSPOON & BAKALAR, supra note 1, at 82.
90. See MARIJUANA, supra note 71, at 362. Symptoms include: weakness, tingling, numbness, stiff-
ness and spasticity. See MARIJUANA, supra note 71, at 362. Spasticity is the involuntary and abnormal
contraction of muscles or muscle fibers. See MARIJUANA, supra note 71, at 362.
91. See MARIJUANA, supra note 71, at 362. A victim of multiple sclerosis claimed that five minutes
after smoking marijuana, she stopped vomiting and no longer felt nauseous and that there was a
noticeable reduction in her spasms. See MARUUANA, supra note 71, at 362.
92. Acquired Immune Deficiency Syndrome is a deadly disease which attacks the immune sys-
tem, making the individual susceptible to opportunistic infections. See GRINSPOON & B AKALAR, supra
note i, at 92.
93. See Grey, supra note 12, at 253. Some of the conditions associated with the AIDS virus
include arthritis, pneumonitis, nephritis, diarrheal syndromes, wasting syndromes and neuropsychotic
manifestations. See Grey, supra note 12, at 253.
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associated with AIDS by stimulating the appetite and allowing the patient
to eat more and gain weight. 94 While smoking marijuana may not cure
the symptoms associated with these disabilities, it may help the victim live
a somewhat normal life.95
B. THE RISKS OF THE MEDICINAL USE OF MARIJUANA
Although marijuana seems at first glance to be an effective treat-
ment for some patients, physicians and researchers have questioned its
effectiveness. 96 Marijuana is made up of many different chemicals, and
it is unknown if any of these chemicals, or those produced when
marijuana is smoked, are beneficial to the user.97 As a result of these
unknown effects, critics claim that the research done on marijuana is
limited and contradictory. 98
Proponents focus on the benefits of marijuana and tend to overlook
the significant short-term side effects and long-term risks associated with
its use. 99 For example, marijuana may cause acute toxic psychosis, panic
attacks, flashbacks, delusions, depersonalization, hallucinations, paranoia,
depression and uncontrollable hostility.' 00 It also is associated with
Amotivational Syndrome 101 and can impair perception, judgement, think-
ing, memory and learning.102
Several of these risks stand out for seriously or terminally-ill
patients.103 Cancer patients' immune systems are weakened by radiation
94. See GRINSPOON & B AKAI.AR, supra note 1, at 92. One California man suffering from AIDS
used marijuana to control nausea and stimulate his appetite. See GRINSPOON & B AKALAR, supra note 1,
at 92. Since he started using the drug, he has kept his weight up, maintained a T-cell count in the
normal range and has shown few symptoms associated with AIDS. See Grey, supra note 12, at 254.
95. See GRINsPooN & BAKALAR, supra note 1, at 69.
96. See Grey, supra note 12, at 254-55.
97. See Grey, supra note 12, at 252. "Marijuana is made up of 400 different chemicals and when
smoked, it produces hundreds more. It is unknown as to which of the compounds produced, if any, are
actually beneficial to the therapeutic user." See Grey, supra note 12, at 252.
98. See Grey, supra note 12, at 252.
99. See 57 Fed. Reg. 10,499, 10,500 (1992). Marijuana is likely to be more cancer-causing than
tobacco; damages brain cells; causes lung problems such as bronchitis and emphysema; may weaken
the body's antibacterial defenses in the lungs; lowers overall blood pressure which could adversely
affect the supply of blood to the head; causes sudden drops in blood pressure, rapid heartbeat and
heart palpitations; suppresses luteinizing hormone secretion in women, which affects the production of
progesterone, an important female hormone; causes anxiety and panic in some users because of its
mind-altering effects; produces dizziness, trouble with thinking, trouble with concentrating, fatigue
and sleepiness; and impairs motor skills. See id. As a plant, marijuana can contain bacteria capable of
causing serious infections in humans. See id.
100. See Crites-Leoni, supra note 7, at 280.
101. Amotivational Syndrome involves "symptoms or behavior pattern characterized by apathy,
loss of effectiveness, and a more passive, introverted personality, which can result from chronic
marijuana abuse." See Crites-Leoni, supra note 7, at 280 n.59 (quoting R. PINGER ET AL., DRUGS:
ISSUES FOR TODAY 394 (2d ed. 1995)).
102. See Crites-Leoni, supra note 7, at 280.
103. See 57 Fed. Reg. at 10,500.
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and chemotherapy, leaving them susceptible to infection. 104 Using mari-
juana to control nausea therefore risks weakening one's immune system
and exposing oneself to the infection-causing bacteria in the plant.105
Glaucoma patients facing possible blindness may actually speed up
the chances of going blind by experimenting with marijuana. 106 While
smoking marijuana lowers eye fluid pressure, it can also cause dramatic
drops in blood pressure and reduce blood supply to the head,107 which
could actually speed up the loss of eyesight.10 8 A patient considering
the use of marijuana should be aware of these risks, as well as the
potential benefits, before deciding whether or not to use the drug.109
Another controversial issue associated with the medicinal use of
marijuana is the debate over whether or not it leads to the use of more
addictive drugs." l0 Many scholars have claimed that addiction 111 is not a
concern for marijuana users.112 A report by the Office of National Drug
104. See id. There are questions, however, regarding whether marijuana smoking is what de-
creases the resistance to infection. See MILLER, supra note 4, at 410. The question is raised because
the chemotherapeutic chemicals themselves weaken the immune system. See MILLER, supra note 4, at
410.
105. See 57 Fed. Reg. at 10,500. As a plant, marijuana can contain bacteria capable of causing
serious infections in humans, such as salmonella enteritidis, klebsiella pneumonia, group D
streptococcus and pathogenic aspergillus. See id.
106. See id. During the 1970s and 1980s, research programs were implemented to give marijua-
na to cancer and glaucoma patients. See id. Unfortunately, these programs failed to follow responsi-
ble scientific methods. See id. Patients took marijuana with their regular medicines, so it is impossible
to say whether marijuana helped them. See id.
107. See id. To be an effective treatment for glaucoma, a drug must: 1) lower intraocular
pressure; 2) do so for periods of time; and 3) actually preserve sight. See id. at 10,501. In order for
marijuana to be effective in this way, unusually large doses are needed. See id. The quantities of the
drug required to reduce intraocular pressure in glaucoma sufferers are large and would require the
inhalation of at least six marijuana cigarettes each day. See id. Analysis of marijuana smoke has
found that benzopyrene, a known cancer-producing chemical, is 70% more abundant in marijuana
smoke than in tobacco smoke. See MILLER, supra note 4, at 411. In fact, smoking one marijuana
cigarette leads to airway deposition of four times as much cancer-causing tar as does tobacco smoke.
See Crites-Leoni, supra note 7, at 282.
108. See 57 Fed. Reg. at 10,500.
109. See id. Large doses of marijuana are needed to relieve the intraocular pressure in the eye.
See id. Therefore, because marijuana smoke contains high amounts of cancer-causing tar, a patient
must determine if the risks of this outweigh the relief of glaucoma symptoms felt by smoking
marijuana. See id.
I10. See id.
11. Addiction is defined as a state of periodic or chronic intoxication detrimental to the indi-
vidual and to society, produced by the repeated consumption of a drug. See GRispooN, supra note 3,
232. Its characteristics include: 1) an overpowering desire or need to continue taking the drug and to
obtain it by any means; 2) a tendency to increase the dose; 3) a psychological and sometimes a
physical dependence on the effects of the drug. See id.
112. See Crites-Leoni, supra note 7, at 281. G.F.W. Ewens of the Punjab Lunatic Asylum in 1904
claimed that marijuana users had no ill effects when forced to stop using the drug against their will.
See GRINSPOON, supra note 3, at 233. In 1925, the Panama Canal Zone Governor's Committee reached
the following conclusions: "[T]here is no evidence that marijuana is a habit forming drug, not only are
there no withdrawal symptoms, but there is no necessity to increase the dosage over time." See
GRINSPOON, supra note 3, at 233. In 1934, W. Bromberg published a study in the American Journal of
Psychiatry which stated that there was a definite difference between marijuana addicts and morphine
or heroin addicts. See GRINSPOON, supra note 3, at 233. With the latter two drugs, the victim must have
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Control Policy,113 however, indicates that there are more people admitted
to drug treatment centers because of marijuana addiction than heroin
addiction. 114
One study shows that twenty percent of those who used marijuana
were three to ten times more likely to go on to use cocaine. 1 5 As one
commentator has noted, "The Partnership for a Drug-Free America
takes the position that marijuana use leads to the use of harder drugs...
'virtually all the heroin and cocaine addicts start out with pot."1 16 The
correlation between marijuana use and the use of more dangerous sub-
stances may make categorizing marijuana as a safe drug impractical. 117
Opponents of the "stepping-stone hypothesis"11 8 state that almost
everyone who uses illicit drugs has smoked marijuana, just as almost
everyone who smokes marijuana has used alcohol first.]1 9 People who
use illicit drugs are somewhat more likely to find themselves in company
where other illicit drugs are available.120 Thus, while the stepping-stone
theory suggests that developing an interest in opiates or cocaine is easier
for individuals who smoke marijuana,121 opponents argue that this does
not itself prove that using one drug leads to or causes the use of
another. 12 2
Therefore, although marijuana may be beneficial to some patients,
others who use it may be subjecting themselves to unknown risks, risks
which may outweigh the benefits.123 Since the research on the medicinal
increasing doses of the drug to feel normal, but a marijuana user wants only to recapture the elated
state into which the drug lifts him; there is no physical disturbance or withdrawal from the drug
because no real tolerance is developed, because the addiction to marijuana is mostly sensual. See
GRiNsPOON, supra note 3, at 233.
113. The office of National Drug Control Policy is organized within the Executive Office of the
President. United States Information Agency: Narcotics and Substance (last modified Oct. 29, 1998)
<http://www.USIA.gov/topical/global/drugs/subab.html>. It coordinates federal, state and local efforts
to control illegal drug abuse and devises national strategies to carry out anti-drug activities. See id.
114. See Crites-Leoni, supra note 7, at 281.
115. See Crites-Leoni, supra note 7, at 282 n.78 (citing Kelber, Cocaine Abuse: Historical Epi-
demiological and Psychological Perspectives, 49 J. CLi i. PSYCH. 3 (Supp. 1988)).
116. See Crites-Leoni, supra note 7, at 282.
117. See Crites-Leoni, supra note 7, at 282 n.81 (quoting Bayer, A Drug-Free Open Society,
WASH. POST, Mar. 12, 1997, at A 19).
118. See GRINSPOON & BAKALAR, supra note 1 at, 147.
119. See GRINSPOON & BAKALAR, supra note 1, at 147. According to opponents of the stepping-
stone theory, it is totally untrue that marijuana leads to other addicting drugs (last visited Jan. 31, 1999)
<http://www.cynisk.ubishops.ca/pzaremba/hemp/info/faq/p3-8.html>.
120. See GRINSPOON & BAKALAR, supra note I, at 147. Another stepping-stone theory is that mari-
juana is the source to the drug subculture, and this subculture is what leads to other drugs. See
GRINSPOON & BAKALAR, supra note 1 at 147.
121. See GRINSPOON & B AKALAR, supra note 1, at 147. There are 40 million people in the United
States who have smoked marijuana at some period in their lives. See GRINSPOON & BAKALAR, supra
note 1, at 147. If the stepping-stone theory were true, the questions remains why there are not tens of
millions of heroin users. See GUNSpooN & BAK.ALAR, supra note 1, at 147.
122. See GRINSPOON & BAKAtAR, supra note 1, at 147.
123. See GPRSPOON & BAcAL i, supra note 1, at 137. In addition to the risks of smoking mari-
juana listed above, marijuana can cause cancer of the mouth, tongue, larynx, jaw, head, neck and
lungs. See Crites-Leoni, supra note 7, at 282; see also supra notes 96-98 and accompanying text.
NOTE
NORTH DAKOTA LAW REVIEW [VOL. 75:555
use of marijuana is inconclusive, more reliable research should be
completed on cancer, glaucoma, AIDS and multiple sclerosis patients,
measuring the detrimental effects, as well as the benefits, over time. 124
Until this is done, the legalization of marijuana for medical purposes
may be premature.125
IV. THE MEDICAL NECESSITY DEFENSE
Marijuana is regulated by both the state and federal governments. 126
The laws 127 regulating chemicals, including marijuana, employ a statu-
tory mechanism placing substances in varying schedules, ranging from
Schedules I to Schedule V.128 These schedules are intended to control
the manufacture, distribution and use of controlled substances and
impose penalties for violations of drug laws. 129
Possession of substances in Schedule I is illegal, except for a narrow
exception for research,130 while possession of substances in Schedules
II through V is legal only under prescription. 131 Marijuana is listed in
Schedule I, making its possession illegal unless it was received under an
approved medical research program.1 32 Therefore, most victims of
cancer, glaucoma, multiple sclerosis and AIDS who smoke marijuana
are breaking the law.133 For those charged with violating the law, the
124. See GRINSPOON & BAKALAR, supra note 1, at 137. Considering that marijuana has provided
relief for patients suffering from cancer, glaucoma, multiple sclerosis and AIDS, it is difficult to state
that marijuana has no medical value. See supra notes 78, 83, 88, 91-92 and accompanying text. How-
ever, because marijuana contains more than 400 chemicals that combust into more that two thousand
chemicals when smoked, including carcinogens and toxins, more research is needed to determine
conclusively whether smoking marijuana is worth the risk. See Crites-Leoni, supra note 7, at 282.
125. See Crites-Leoni, supra note 7, at 279.
126. See Seeley v. State, 940 P.2d. 604, 607 (Wash. 1997) (stating that federal and state govern-
ments have established laws to control the manufacture, distribution, and use of controlled substances
and that penalties are imposed for violations).
127. See supra notes 46-49 and accompanying text.
128. See Controlled Substances Act, 21 U.S.C § 812 (1994). Substances are placed in schedules
based on their potential for abuse and currently accepted medical value. See id. Substances in
Schedule I are the most addicting and have no medical value, where as substances in Schedule V have
a low potential for abuse and have a currently accepted medical value. See id.; see also supra note 49
and accompanying text.
129. See Seeley, 940 P.2d at 607.
130. See supra notes 61, 64 and accompanying text. The research programs provided free, pre-
rolled marijuana cigarettes to about a dozen approved patients. See Vitiello, supra note 64, at 756.
The program was under the control of three separate agencies: the FDA (responsible for evaluating
the medical merits of applications), the DEA (responsible for enforcing legal procedures to secure
marijuana), and the National Institute of Drug Abuse (responsible for the cultivation of marijuana on
its Mississippi farm). See Vitiello, supra note 64, at 756.
131. See Seeley, 940 P.2d at 607. Examples of substances in Schedule I are heroin, morphine
and marijuana; Schedules Il-V contain opium, cocaine and amphetamines. See 21 U.S.C § 812.
132. See 21 U.S.C. § 812. In order to qualify for the research program, the applicant must
demonstrate that the benefits of the drug outweigh any possible risk involved. See Vitiello, supra note
64, at 756.
133. See Seeley, 940 P.2d at 607.
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defense of medical necessity can sometimes provide a way to escape
criminal penalties. 134
Necessity has been defined as an "irresistible compulsion; a power
or impulse so great that it admits no choice of conduct." 135 At common
law, the necessity defense was known as the "choice of evils" defense,
because the actor was threatened by a force that could be overcome only
by violating the law. 136
Today, the necessity defense involves a balancing test to determine
whether a criminal act was committed in order. to avoid a greater
harm. 137 If so, an otherwise criminal act is considered justified, and the
actor is therefore acquitted.138 In United States v. Aquilar,139 the Ninth
Circuit Court of Appeals determined that, in order to invoke the necessi-
ty defense, the defendant must show that: 1) he or she was faced with a
choice of evils and chose the lesser evil; 2) he or she acted to prevent
imminent harm; 3) he or she reasonably anticipated a direct causal
relationship between his or her conduct and the harm to be averted; and
4) he or she had no legal alternative to violating the law.140 Therefore,
the defense recognizes that there are times when a "technical breach of
the law will bring about a more desirable result than adherence to the
law."141 This defense would seem to help those who suffer from cancer,
glaucoma, AIDS and multiple sclerosis and who believe the relief they
receive from smoking marijuana outweighs the harm that could result by
breaking the law. 142 The majority of courts, however, disagree.143
134. See generally Todd H. Whilton, Comment, Commonwealth v. Hutchins: A Defendant Is
Denied the Right to Present a Medical Necessity Defense. 27 NEw ENG. L: REV. 1101 (1993).
135. See id. at 1102
136. See id.
[A] man may have motives adverse to the law of such strength as to overcome any fear
that can be inspired by the terror of any legal punishment. He may be urged to the com-
mission of a crime by motives more proximate and imperious than any sanction the law
can hold out. In such cases, as the threats of the law are necessarily ineffective, they
should not be made, and their fulfillment is gratuitous cruelty-the infliction of needless
and uncompensated evil.
See id. (quoting W.H. Hitcher, Necessity as a Defense in Criminal Cases, 33 DICK. L. REV. 138, 139-40
(1928)).
137. See Laura J. Schulkind, Note, Applying the Necessity Defense to Civil Disobedience Cases,
64 N.Y.U. L. REV. 79, 82 (1989). For example, a person stranded in a blizzard may break into a home
to avoid freezing to death. See id. He or she thus breaks the law, but he or she does so only to avoid
the greater harm of dying. See id.
138. See id.
139. 883 F.2d 662 (9th Cir. 1989), cert. denied, 498 U.S..1046 (1991).
140. See United States v. Aquilar, 883 F.2d 662, 693 (9th Cir. 1989), cert. denied, 498 U.S. 1046
(1991).
141. See Schulkind, supra note 137, at 82.
142. See Whilton, supra note 134, at 1102.
143. See, e.g., State v. Hanson, 468 N.W.2d 77 (Minn. Ct. App. 1991); State v. Tate, 505 A.2d
941 (N.J. 1986); Seeley v. State, 940 P.2d 604 (Wash. 1997).
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The defendant in Seeley v. State, 144 a Washington case, suffered
from cancer and smoked marijuana to control the side effects of chemo-
therapy.145 He contended that he had a fundamental right' 46 to have
marijuana prescribed as his preferred medical treatment to combat the
nausea and vomiting associated with chemotherapy.147 However, the
court held that a terminally-ill patient is not a part of a suspect class148
and therefore has no fundamental right to have marijuana prescribed as
his preferred treatment.149 The decision shows that courts are reluctant
to expand the conception of fundamental rights beyond those liberties
tha are deeply embedded in our nation's history and tradition.150
In State v. Hanson,151 a 1991 Minnesota case, the defendant suf-
fered from epilepsy and began smoking marijuana to combat the side
effects of his anti-seizure medication.1 52 He was convicted of marijuana
possession and attempted to use the medical necessity defense.' 53 The
trial court concluded that it could not allow the medical necessity de-
fense because doing so would alter the legislative decisionl5 4 to classify
144. 940 P.2d 604, 606 (Wash. 1997). Seeley did not argue the medical necessity defense, but
instead relied on his constitutional rights to use his preferred treatment for his medical needs. See
Seeley v. State, 940 P.2d 604, 612 (Wash. 1997).
145. See id.
146. Fundamental rights are those rights that are explicitly or implicitly guaranteed in the Consti-
tution. See BLACK'S LAW D IcIoNARY 674 (6th ed. 1990). Seeley contended that placing marijuana in
Schedule I threatened his fundamental rights by making marijuana inaccessible. See Seeley, 940 P.2d
at 612. He contended that placement on the schedule infringed not a general right to smoke
marijuana, but rather a right to have marijuana prescribed as one's preferred medicine. See id.
147. See Seeley, 940 P.2d at 611.
148. The court employs the "strict scrutiny" standard in determining the legitimacy of classifica-
tions based upon a trait which itself seems to contravene established constitutional principles, so that
any purposeful use of the classification may be deemed "suspect." See BLACK'S LAW DICTIONARY
1446 (6th ed. 1990). Examples include race, gender and national origin. See id.
149. See Seeley, 940 P.2d at 613.
150. See id. Examples of rights deeply embedded in our history include religious beliefs, the
right to privacy, the right to marry, the right to bear children and the institution of family. See
generally Cruzan v. Missouri Department of Health, 497 U.S. 261 (1990); Bowers v. Hardwick, 478
U.S. 186 (1986); Mills v. Rogers, 457 U.S. 291 (1982); Skinner v. Oklahoma ex rel. Williamson, 316
U.S. 535 (1942).
151. 468 N.W.2d 77 (Minn. Ct. App. 1991).
152. See generally State v. Hanson, 468 N.W.2d 77 (Minn. Ct. App. 1991). Epilepsy is a condi-
tion in which certain brain cells become abnormally excitable and spontaneously discharge in an
uncontrolled way, causing a seizure. See GRINSPOON & BAKALAR, supra note 1, at 58. Some of the side
effects from anticonvulsant drugs include bone softening, pernicious anemia (reduced production of
red blood cells), swelling of the gums and emotional disturbances. See GRINSPooN & BAKALAR, supra
note 1, at 58.
153. See Hanson, 468 N.W.2d at 78. The defense of medical necessity is available to a person
charged with a crime, provided that the proposed medical use is so unique or effective that it would
have been an inappropriate criminal action. See id. at 77.
154. The Minnesota Legislature has attached criminal penalties to the possession, sale or cultiva-
tion of marijuana. MINN. STAT. §§ 152.01(7), .02(1) (1990). Also, the statutory classification of mari-
juana as a Schedule I substance implies a determination that marijuana has no currently accepted
medical use. See id. Therefore, allowing the medical necessity defense would contradict the impli-
cation that marijuana has no accepted medical value. See id.
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marijuana as a Schedule I substance and would allow another use for
marijuana other than the legislatively-permitted one of limited medical
research. 155
The Minnesota appellate court agreed with the trial court and held
that "[t]he defense of necessity is available only in situations wherein the
legislature has not itself, in its criminal statute, made a determination of
values. If it has done so, its decision governs."1 56 The Hanson court
therefore refused to acknowledge that marijuana has any medical value
until the legislature acknowledges it, meaning the medical necessity
defense was unavailable. 157
Finally, State v. Tate,158 a New Jersey case, involved a quadriplegic
defendant.159 The spasticity caused by this condition was so severe that
it disabled Tate; he smoked marijuana to provide relief.160 After being
arrested for possession of over twenty-five grams of marijuana, Tate
relied on the defense of medical necessity.161
He argued that the defense provided a standard for determining
whether conduct that would otherwise constitute a criminal offense was
justifiable by reason of necessity. 162 The court considered the New Jer-
sey Legislature's determination, which set forth three limiting criteria
governing the medical necessity defense.163 These criteria were: 1) con-
duct is justifiable only to the extent permitted by law; 2) the defense is
unavailable if either the New Jersey Code or other statutory law defining
the offense provides exceptions or defenses dealing with the specific
situation involved; and 3) the defense is unavailable if a legislative
purpose to exclude the justification otherwise plainly appears.164
In considering these statutory criteria, the court first held that the
possession of marijuana was not permitted by law.165 It also noted that
the New Jersey Code contained provisions dealing with possession of
marijuana and concluded that the legislature had not given the court the
155. See Hanson, 468 N.W.2d at 78.
156. See id.
157. See id. at 79.
158. 505 A.2d 941 (N.J. 1986).
159. See State v. Tate, 505 A.2d 941, 942 (N.J. 1986). Quadriplegia is a condition resulting from
a spinal cord injury near the neck, resulting in paralysis of the muscles in the body. See GRINspooN &
BAKALAR, supra note 1, at 82.
160. See GRINSOON & BAXALAR, supra note 1, at 82. Spasticity is involuntary and abnormal con-
traction of muscles or muscle fibers. See MARIJUANA, supra note 71, at 363.
161. See Tate, 505 A.2d at 942.
162. See id. In other words, Tate claimed that illegally smoking or possessing marijuana was
justified because of his need to control his spasticity to live a normal life. See id.
163. See id. at 944.
164. See id. (citing N.J. STAT. ANN. 2C:3-2(a)).
165. See id.
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discretion to accept the necessity defense. 166 Further, the court wrote, the
legislature had allowed for marijuana to be obtained for certain medical
uses from the New Jersey Commissioner of Health.16 7 Therefore,
because the legislature provided the legal alternative of applying to the
state's research program, the illegal alternative was not necessary and the
resort to it was not justified.168
While the majority of courts reject the medical necessity defense, a
few do find it valid. In the 1979 case of State v. Diana, 169 the defen-
dant, who suffered from multiple sclerosis, claimed the medical necessity
defense to a charge of possession of marijuana.170 The defendant
claimed that: 1) His experience was supported by medical research; 2)
he used the marijuana because the drugs which his doctors prescribed
for him left unpleasant side effects and were not as effective as marijuana
in relieving his symptoms; and 3) he attempted to obtain marijuana
legally through his physician but was refused the request because of the
illegal status of the drug. 17 1 The court took the view that the medical
necessity defense is justified in limited and special circumstances, which
were present in this case. 172 Therefore, the court held that the defendant
could assert a medical necessity defense, provided that he give corrobo-
rating medical support.173
166. See id.
167. See id. at 946.
168. See id. at 946-47. In his dissent, Justice Handler created a test that would allow medical
necessity as a legitimate justification defense. See id. The test is drawn from common law and would
require: 1) the defendant must be suffering from a condition that involves intolerable pain, or an
immediate, actual, or substantial treat to his life, health, vital senses, or basic physical or mental well
being; 2) the suffering experienced by the defendant from the harmful condition forces the defendant
to resort to unlawful conduct involving the controlled substance; 3) there must be an absence of any
other lawful treatment which would relieve the symptoms; 4) the defendant's decision to resort to the
unlawful possession or use of the prohibited substance must be based on reasonable necessity, which
includes a good-faith effort to relieve the harmful condition through accepted medical treatment; 5)
competent medical expert evidence must be submitted demonstrating that i) the harmful condition was
medically genuine, ii) the unlawful conduct eliminated or materially and substantially relieved the
condition, and iii) that there was no alternative treatment or substance legally available for the harmful
condition; 6) it must be shown that the situation precipitating the decision to engage in unlawful
conduct was not brought about by any actions of the defendant; and 7) it must appear that allowing the
defendant to obtain relief from the harmful condition is more important than criminal punishment for
the unlawful conduct. See id. at 954-55.
169. 604 P.2d 1312 (Wash. Ct. App. 1979).
170. See State v. Diana, 604 P.2d 1312, 1314-15 (Wash. Ct. App. 1979).
171. See id. at 1315.
172. See id. at 1314-15. The court stated that medical necessity would exist in this case if the
court could find that: I) the defendant reasonably believed his use of marijuana was necessary to
minimize the effects of multiple sclerosis; 2) the benefits derived from its use are greater that the harm
sought to be prevented by the controlled substances law; and 3) no drug was as effective in minimizing
the effects of the disease. See id. at 1317.
173. See id.
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Similarly, the defendant in United States v. Randall1 74 grew and
used marijuana to treat his glaucoma; he was arrested for possession and
used the medical necessity defense. 175 In determining whether the evil to
be avoided by the defendant's act was greater than the possession and
personal use of marijuana, the court balanced his interest in preserving
his sight against the government's interest in controlling the drug
problem. 176 The court resolved the balance in favor of the defendant
and held that the defendant's right to preserve his sight outweighed the
government's interest in outlawing the drug. 177
Finally, in Jenks v. State, 178 AIDS patients were arrested for cultiva-
tion of cannabis and possession of drug paraphernalia. 179 They used the
medical necessity defense, claiming they did not intentionally bring
about the circumstances which precipitated the unlawful act. 180 The de-
fendants claimed they could not receive the same relief from the effects
of AIDS from less offensive alternatives, and the evil sought to be avoid-
ed was more heinous than the unlawful act perpetuated to avoid it.181
The Jenks court held that the defendants successfully proved the
three elements necessary for the medical necessity defense.182 They had
not intended to contract AIDS; the treating physicians supported their
assertion that no other drug available would control the nausea as
effectively as marijuana; and they established that failure to control the
174. See 104 Daily Wash. L. Rptr. 2249 (D.C. Super. Ct. 1976).
175. See generally United States v. Randall, 104 Daily Wash. L. Rptr. 2249 (D.C. Super. Ct.
1976). The defendant believed marijuana neutralized the inner-ocular pressure and lessened the
visual distortion caused by glaucoma. See id.
176. See id.
177. See id. The Randall court placed special emphasis on the importance of an individual's
right to preserve and protect his or her own health and body. See id. at 2252. See also Roe v. Wade,
410 U.S. 113 (1973) (emphasizing that a person has a right to privacy and a right to protect one's own
health and body).
178. 582 So. 2d 676 (Fla. Dist. Ct. App. 1991).
179. See generally Jenks v. State, 582 So. 2d 676 (Fla. Dist. Ct. App. 1991). The defendants
smoked marijuana to control the nausea caused by side effects from AIDS treatment medications. See
id. at 676.
180. See id. Kenneth Jenks inherited hemophilia from his mother and contracted AIDS from a
blood transfusion. See id. at 677. Kenneth unknowingly passed it to his wife Barbara. See id.
181. See id. at 679. In other words, the Jenks argued that the nausea caused by AIDS was a
worse evil than the illegal possession of marijuana used to avoid the nausea. See id.
182. See id. at 679-80. The three elements are: 1) the defendant did not intentionally bring about
the circumstances which precipitated the unlawful act; 2) the defendant could not accomplish the
same objective using a less offensive alternative available to the defendant; and 3) the evil sought to
be avoided is more heinous than the unlawful act perpetrated to avoid it. See id. at 679. The court
also stated that although there is no specific legislative acceptance of the necessity defense in Florida,
the defense was recognized at common law. See id. at 678. Florida adopted a statute which provides
that the common and statute laws of England are in force as long as they are not inconsistent with acts
of the legislature. See id. Therefore, because there has been no clearly-expressed legislative re-
jection of such a defense in Florida, the Jenks were justified in using the medical necessity defense.
See id.
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effects of AIDS would put their lives in jeopardy.183 Based upon these
facts, the court held that the defendants were justified in using the
medical necessity defense.184
As this discussion shows, courts are split on whether or not the
necessity defense should be accepted.' 8 5 The majority of courts are
reluctant to interpret the legislative statutes, and they therefore reject the
defense.186 The question remains whether the courts' reluctance is affect-
ing the movement towards legalization of marijuana.187
V. THE LEGALIZATION MOVEMENT
Federal, state and local governments use the legislative process to
control and direct standards for drug control to ensure a safe and organ-
ized country.188 However, some believe that regulation is unnecessary. 8 9
Dr. Lester Grinspoon, a proponent of marijuana legalization, suggests
that "although the risks of marijuana are not fully known, it should be
available to those patients who may benefit from its use."190 Therefore,
proponents for the legalization of marijuana have been fighting for
years to end what they see as the unnecessary regulation of marijuana.191
On the other hand, opponents of legalization, including the federal
government, are furiously fighting to keep marijuana within its restrictive
183. See id. at 679-80. The Jenks' doctor, Dr. Thomas D. Sunnenberg, testified that he had been
unable to find any effective drug for treating the defendants' nausea, the nausea was so debilitating
that the defendants could die if it was not controlled, and the only drug that controlled their nausea
effectively was marijuana. See id. at 677-78.
184. See id.
185. See supra notes 149-79 and accompanying text (describing case law examining the medical
necessity defense). See also, e.g., U.S. v. Randall, 104 Daily Wash. L. Rptr. 2249 (D.C. Super. Ct.
1976); Jenks v. Florida, 582 So. 2d. 676 (Fla. Dist. Ct. App. 1991); State v. Tate, 505 A.2d 941 (N.J.
1986); State v. Hanson, 468 N.W.2d 77 (Minn. Ct.App. 1981); Washington v. Diana, 604 P.2d 1312
(Wash. App. Div. 1979).
186. See supra note 185.
187. See supra note 185.
188. See Crites-Leoni, supra note 7, at 285. In 1970, Congress enacted the Controlled Substances
Act (CSA) to unify all drugs subject to federal regulation; it established increasing levels of control on
the basis of abuse potential and lack of therapeutic usefulness. See Controlled Substances Act, 21
U.S.C. § 812 (1994).
189. See Crites-Leoni, supra note 7, at 285. The National Organization for the Reform of Mari-
juana Laws (NORML) and the Alliance for Cannabis Therapeutics (ACT) are two of the largest
organizations which oppose the government's regulation of marijuana. See Crites-Leoni, supra note 7,
at 285.
190. See Crites-Leoni, supra note 7, at 285. Dr. Grinspoon is one of the leading proponents for
marijuana legalization. See GRINSPOON, supra note 3, at vii. Dr. Grinspoon has been studying cannabis
since the 1960s and has written several books on marijuana's usefulness. See GRINSPOON, supra note 3,
at viii.
191. See GwuNspooN, supra note 3, at viii. Since the early 1970s, NORML and ACT have been
fighting to end the regulations on marijuana in order to allow needy individuals to benefit from the
effects of the drug. See GRINSPOON, supra note 3, at viii.
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controls. 192 One such fight involved a series of attacks on marijuana's
placement on Schedule I of the Controlled Substances Act.
A. THE COURTS' ROLE IN THE LEGALIZATION MOVEMENT
The National Organization for the Reform of Marijuana Laws
(NORML) is an educational organization which opposes the govern-
ment's punishment of individuals who smoke marijuana for medical
use. 193 On May 18, 1972, NORML petitioned the Bureau of Narcotics
and Dangerous Drugs to remove marijuana from the Controlled Sub-
stances Act or, in the alternative, to transfer marijuana from Schedule I to
Schedule V.194 The petition was rejected, due in part to the belief that
the reclassification of marijuana would violate the United States' treaty
obligations under the Single Convention on Narcotic Drugs,195 an inter-
national treaty regulating and classifying narcotics. NORML appealed
this decision, and, in NORML v. Ingersoll,196 the District of Columbia
Circuit Court of Appeals reviewed the rejection of the petition.197
After reviewing NORML's petition, the Ingersoll court remanded
the case for further proceedings.198 The court held that the petition
should be considered based on the evidence presented, not on the treaty
obligations.199 In a subsequent hearing, experts testified that the terms
of the Convention did not prevent marijuana from being rescheduled.200
However, the court indicated that marijuana could not be removed from
192. See GRINsPooN, supra note 3. at viii
193. See MARIJUANA, supra note 71, at ix.
194. See National Org. for the Reform of Marijuana Laws (NORML) v. Ingersoll, 497 F.2d 654,
655 (D.C. Cir. 1974). Schedule I substances have a high potential for abuse and have no currently-
accepted medical value in the United States. See id. Schedule V substances have a low potential for
abuse and have a currently accepted medical use in treatment in the United States. See Controlled
Substances Act, 21 U.S.C. § 812 (1994).
195. See Ingersoll, 497 F.2d at 657. The Single Convention on Narcotic Drugs was a treaty
signed by members of the United Nations establishing several classifications, or schedules, of substanc-
es. See National Org. for Reform of Marijuana Laws (NORML) v. Drug Enforcement Administration
(DEA), 559 F.2d 735, 739 (D.C. Cir. 1977). Parties to the Single Convention are required to limit
production, distribution and possession of the drugs to an authorized medical and scientific purpose; to
license and control all persons engaged in the manufacture or distribution of the drugs; and to prepare
detailed estimates of national drug requirements. See id. at 739-40. In contrast to the Controlled
Substances Act, the Convention prescribes different controls of various parts of the cannabis plant.
See id. at 739. As defined in Article I of the treaty, "cannabis" means the flowering or fruiting tops of
the cannabis plant (excluding the seeds and leaves). See id. Cannabis is listed in Schedules I and IV
of the Convention and is thus subject to the controls applicable to each of the classifications. See id.
196. 497 F.2d 654 (D.C. Cir. 1974).
197. See NORML v. Ingersoll, 497 F.2d 654, 656 (D.C. Cir. 1974).
198. See id. at 660.
199. Id.
200. See id. As a result of the treaty's definition of cannabis, the leaves are not subject to the
controls of the Schedules. See NORML v. DEA, 559 F.2d at 739-40. Therefore, because the United
States relies heavily on the effects of the leaves, rescheduling marijuana would not contradict the
Convention. See id.
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Schedule I because it has no currently accepted medical use in the
United States.201
In October 1975, the court decided NORML v. DEA,202 in which
NORML again asked the court to review the rejection of the removal of
marijuana from Schedule 1.203 This review focused on the factors the
DEA uses to place substances in schedules, since the court found that the
legislative history of the Controlled Substance Act indicated that medical
use is only one factor to be considered in making this decision.204
Adding to the debate, the DEA205 admitted that it does not always place
substances lacking any medical usefulness in Schedule 1.206 The DEA's
chief counsel also testified that several substances listed in Schedule II
have no currently accepted medical use, although they did have a high
potential for abuse. 207 Thus, the chief counsel concluded that marijuana
could be reclassified into Schedule II without a currently accepted
medical use, as long as it did not have a high potential for abuse. 20 8
Therefore, the court held that the Administrator of the Drug
Enforcement Administration acted prematurely in refusing to reschedule
marijuana. 20 9 The court remanded the case for further proceedings,
directing the DEA to refer the NORML petition to the Secretary of
Health, Education and Welfare for medical and scientific findings and
recommendations for rescheduling. 210  The DEA did so; the Secretary
then recommended against reclassification, and the DEA agreed. 211
NORML, later joined by the Alliance for Cannabis Therapeutics
(ACT),212 continued to appeal the DEA's denial to reclassify mari-
201. See id.
202. 559 F.2d 735, 743 (D.C. Cir. 1977).
203. See NORML v. DEA, 559 F.2d 735, 743 (D.C. Cir. 1977).
204. See H.R. REP. No. 91-1444, 91st Cong. 2d Sess., pt. 1, at 34. The legislative history states
that the substance's potential for abuse is also a key criterion used in scheduling substances. See id.
205. The Controlled Substance Act gave the Attorney General and the Secretary of Health, Edu-
cation and Welfare the authority to reschedule controlled substances, but they are not allowed to do so
unless the DEA makes certain statutorily mandated findings. See Alliance for Cannabis Therapeutics
(ACT) v. DEA, 930 F.2d 936, 937 (D.C. Cir. 1991). These findings include scientific evidence of the
drug's pharmacological effect and the state of current scientific knowledge regarding the drug or
other substances. See id. at 938.
206. See NORML v. DEA, 559 F.2d at 748.
207. See id.
208. See id.
209. See id. at 749-51.
210. See id. at 757.
211. See NORML v. Bell, 488 F. Supp. 123, 125 n.3 (D. D.C. 1980). The Administrator of the
DEA followed the recommendations of the Secretary of Health, Education and Welfare that
marijuana remain in Schedule I because research indicates that marijuana has no medical or scientific
properties. See id.
212. The Alliance for Cannabis Therapeutics is a nonprofit organization founded in 1980 whose
goal is to make marijuana available for prescription. See GRINSPOON & BAKALAR, supra note 1, at 34.
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juana. 213 In Alliance for Cannabis Therapeutics (ACT) v. DEA,214 ACT
and NORML argued that the refusal to reschedule marijuana was due to
misapplication of the statutory phrase "currently accepted medical
use." 215 The DEA, however, claimed that the use of this phrase was
reasonable, stressing that it employed an eight-factor test in its schedul-
ing decisions and that this test provided a sufficient basis for a Schedule
I classification for marijuana.216
The ACT court looked at this test to determine if the DEA had
properly placed marijuana in Schedule 1.217 The court determined the
DEA reasonably interpreted the test, with the exception of factors four,
five and eight. 2 18 Factor four refers to the general availability of the
substance and information regarding the substance and its use; factor
five considers the recognition of the drug's clinical use; and factor eight
focuses on the recognition and use of the substance by a substantial
amount of medical practitioners. 2 19 The court expressed concern about
these criteria because they were impossible to meet: One cannot show
that a Schedule I drug is in general use or general availability because
the drug is, by definition, illegal.220 Further, a Schedule I drug is not
considered to have an accepted medical use, so it would not be in the
pharmacopeia, medical references, journals, or textbooks. 221 The court
therefore remanded the petition back to the DEA for further review. 222
The DEA again denied the petition: Marijuana failed all points of the
213. See McGuire, supra note 47, at 75.
214. 930 F.2d 936 (D.C. Cir. 1991).
215. See Alliance For Cannabis Therapeutics (ACT) v. DEA, 930 F.2d 936, 939 (D.C. Cir. 1991).
216. See id. at 938. The eight factor test consists of the following:
I. Scientifically determined and accepted knowledge of its chemistry;
2. The toxicology and pharmacology of the substance in animals;
3. Establishment of its effectiveness in humans through scientifically designed clinical
trials;
4. General availability of the substance and information regarding the substance and its
use;
5. Recognition of its clinical use in generally accepted pharmacopeia, medical
references, journals or textbooks;
6. Specific indications for the treatment of recognized disorders;
7. Recognition of the use of substance by organizations or associations of physicians;
and
8. Recognition and use of the substance by a substantial segment of the medical
practitioners in the United States.
53 Fed. Reg. 5,156 (1988).
217. See ACT, 930 F.2d at 940.





NORTH DAKOTA LAW REVIEW [VOL. 75:555
DEA's new, medically accepted standard, which did not contain any
criteria impossible for a Schedule I drug to meet. 223
In 1994, ACT appealed the DEA Administrator's 1992 Final Order,
but the court declined to review the petition. 224 Finally, after a twenty-
year effort by marijuana legalization advocates who challenged each
order denying their petitions, the DEA's 1992 Final Order withstood
appellate scrutiny.2 25 Federal officials had stood their ground, following
their assertion that there is "no clinical evidence demonstrat[ing] that
smoked marijuana is good medicine." 226 While the federal government
has held firm, however, the states appear more willing to recognize
medical potential for the drug.22 7
B. THE STATES' ROLE IN THE LEGALIZATION MOVEMENT
Laws at the state level, generally mirror the federal CSA, thus
placing marijuana in the highly restrictive Schedule 1.228 Although
many states have recognized the potential therapeutic use of the drug by
implementing research programs, many states retain a highly restrictive
drug schedule.22 9 Further, because drug abuse is viewed as a social
problem, many state legislatures refuse to enact legislation for the
medicinal use of marijuana. 230
223. See id. On remand, the DEA Administrator explained that factors four and eight played no
role in the decision, whereas factor five determined that marijuana is absent from the official pharma-
copeia because marijuana's chemistry is neither known nor reproducible. See 57 Fed. Reg. 10,499,
10,506-08 (1992). The Administrator then condensed and clarified the initial medically accepted
standard into a five point test:
1) The drug's chemistry must be known and reproducible;
2) there must be adequate safety studies;
3) there must be adequate and well-controlled studies proving efficacy;
4) the drug must be accepted by qualified experts; and
5) the scientific evidence must be widely available.
See id.
224. See Alliance for Cannabis Therapeutics (ACT) v. DEA, 15 F.3d 1131 (D.C. Cir. 1994).
225. See McGuire, supra note 47, at 79.
226. See McGuire, supra note 47, at 78 n.45 (quoting Arizona and California Drug-use Initia-
tives: Hearings Before the Senate Committee on the Judiciary, 104th Cong., 1st Sess. (1996)
(testimony of Retired General Barry McCafferty, Director, Office of Nat'l Drug Control Policy).
227. See McGuire, supra note 47, at 78.
228. See McGuire, supra note 47, at 78-79. For example, the Washington Controlled Substance
Act's criteria for Schedule I state that a substance shall be placed in Schedule I if it is found that the
substance has a high potential for abuse and has no accepted medical treatment in the United States.
See WASH. REv. CODE § 69.50.203 (1995). The North Dakota Controlled Substance Act also desig-
nates marijuana as a Schedule I drug and mirrors the Federal Act. See N.D. CENT. CODE § 19-03.1-04
(Y997).
229. See supra note 67 and accompanying text.
230. See Crites-Leoni, supra note 7, at 276 (stating that preventing drug abuse before it starts is a
key to long-term success in resolving the drug problem). States who refuse to enact legislation, may




North Dakota's stance on the legalization movement is reflected by
the state's inaction on the medicinal use of marijuana. 231 In fact, the
legislature has not approached the subject of medical marijuana in
nearly twenty years.2 32 North Dakota's statute currently follows the
CSA's classification of substances into schedules. 233 In North Dakota, as
in the CSA, marijuana falls into the Schedule I classification. 234 North
Dakota also has mandatory terms of imprisonment and fines for use of
controlled substances classified in Schedule 1.235 These strict penalties
further indicate that North Dakota is against the medicinal use of
marijuana. 23 6
The legislature has only addressed the issue once, without changing
its basic stance. On January 3, 1979, the North Dakota Legislature intro-
duced the Controlled Substances Therapeutic Research Act. 237 The Act
would have allowed the controlled use of marijuana to alleviate nausea
and other effects of chemotherapy and glaucoma.238 The Act also called
231. See N.D. CENT. CODE § 19-03.1-02(1997). The substances are placed in schedules according
to the following factors:
a) The actual or relative potential for abuse;
b) The scientific evidence of its pharmacological effect, if known;
c) The state of current scientific knowledge regarding the substance;
d) The history and current pattern of abuse;
e) The scope, duration and significance of abuse;
f) The risk to the public health;
g) The potential of the substance to produce psychic or physiological dependence
liability; and
h) Whether the substance is an immediate precursor of a substance already
controlled under this chapter.
See id.
232. H.R. 1050, 47th Leg. (N.D. 1979).
233. See id.
234. See ND CENT. CODE § 19-03.1-04 (1997). The Schedule I test states that a substance shall
be placed in Schedule I if it is found that the substance: 1) Has high potential for abuse and 2) has no
accepted medical use in treatment in the United States or lacks accepted safety for use in treatment
under medical supervision. See id.
235. See N.D. CENT. CODE § 19-03.1-23 (1997). Any persons who violates the statute is subject
to the following penalties:
A) A controlled substance classified in schedule I or 11 which is a narcotic drug, or
methamphetamine, is guilty of a class A felony and must be sentenced:
I ) For a first offense, to imprisonment for a least a year and a day.
2) For a second offense, to imprisonment for at least five years.
3) For a third or subsequent offense, to imprisonment for twenty years.
See id.
236. See id.
237. See id. Today, 19 states have passed laws permitting therapeutic research programs and
physician privilege to prescribe marijuana. See also supra note 67.
238. See H.R. 1050, 47th Leg. (N.D. 1979).
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for further research and experimentation regarding the use of mari-
juana. 239 The research was to be limited to cancer chemotherapy
patients and glaucoma patients who would qualify for treatment accord-
ing to a review board composed of licensed physicians certified by the
American boards of opthamology, internal medicine and psychiatry. 240
The board would also have certified practitioners and licensed pharma-
cies for participation in distribution of marijuana.2 41 The Act would
have been temporary and would have expired at midnight on June 30,
1981.242 However, on January 12, 1979, the Legislature voted down the
bill by a vote of four yeas and ninety-two nays. Thus, North Dakota has
never had any provisions for legalized marijuana, even for studying the
issue.
2. Pro-Legalization Movement
At the other end of the spectrum, some states are willing to recog-
nize marijuana's medicinal potential.2 43 Despite the nation's drug abuse
problem, these states have put the needs of patients with debilitating
illnesses first and have allowed marijuana use under limited circum-
stances. 244 Recently, eight states have gone one step further by allowing
the medical use of marijuana. 245
239. See id.
240. See id. The patient qualification review board would have reviewed necessary information
concerning applicants for the program. See id. at 3. Members of the board would have been re-
imbursed for their attendance at the rate of $40 per day. See id.
241. See id. To distribute the marijuana, the review board would have made application under
this Act to the national institute on drug abuse. See id. at 4. The board would then have transferred
marijuana to a licensed pharmacy or pharmacies for distribution to certified patients upon the written
prescription of certified practitioners pursuant to the Act. See id.
242. See id. The Act was temporary in order to research the effects of marijuana on cancer and
glaucoma patients. See id. at 5. The review board was to have reported its findings and recommenda-
tions to the governor and the legislature. See id.
243. See McGuire, supra note 47, at 79. See also supra note 67 and accompanying text.
244. See McGuire, supra note 47, at 79. The research programs exempt participants from crimi-
nal prosecution for use, possession or cultivation of marijuana. See McGuire, supra note 47, at 79.
The programs are research oriented; while they do not give credence to marijuana's medicinal
efficacy, they embrace its therapeutic potential. See McGuire, supra note 47, at 79.
245. The following states have passed measures allowing the medicinal use of marijuana:
Alaska, Arizona, Colorado, Nevada, Washington and the District of Columbia. NORML (last visited
Feb. 2, 1999) <http./www.norml.org/news/archives/98-11-04.shtml>.
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In 1996, California voters approved Proposition 215,246 an expan-
sive medical marijuana initiative. 247 The initiative's scope includes
making marijuana available to patients suffering from diseases ranging
from AIDS to migraines. 248 Arizona voters similarly approved Proposi-
tion 200,249 which legalized the medicinal use of marijuana, in 1996.250
This "Drug Medicalization, Prevention and Control Act" 251 is broader
than California's Proposition 215 and would permit doctors to prescribe
246. Proposition 215, the Compassionate Use Act of 1996, consists of:
A) To ensure that seriously ill Californians have the right to obtain and use marijuana
for medical purposes where that medical use is deemed appropriate and has been
recommended by a physician who has determined that the person's health would
benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS,
chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which
marijuana provides relief.
B) To ensure that patients and their primary caregivers who obtain and use marijuana
for medical purposes upon the recommendation of a physician are not subject to
criminal prosecution or sanction.
C) To encourage the federal and state governments to implement a plan to provide for
the safe and affordable distribution of marijuana to all patents in medical need of
marijuana.
2) Nothing in this section shall be construed to supersede legislation prohibiting
persons from engaging in conduct that endangers others, nor to condone the
diversion of marijuana for non-medical purposes.
c) Notwithstanding any other provisions of law, no physician in this state shall be
punished or denied any right privilege, for having recommended marijuana to
a patient for medical purposes.
d) Section 11357 of the California Code, relating to the possession of marijuana,
and Section 11358, relating to the cultivation of marijuana, shall not apply to a
patient, or to a patient's primary care giver, who possesses or cultivates
marijuana for the personal medical purposes of the patient upon the written or
oral recommendation or approval of a physician.
CAL. HEALTH & SAFETY CODE § 11362.5 (1996).
247. See id.
248. McGuire, supra note 47, at 92.
249. Proposition 200 states:
A. Notwithstanding any law to the contrary, including the Federal Food, Drug and
Cosmetic Act and the controlled substances act, any physician who is licensed may
prescribe a schedule I drug to treat a debilitating disease or to relieve the pain and
suffering of a seriously ill patient or terminally ill patient.
B. A physician who is licensed shall document that scientific research exits which
supports the use of the schedule I drug to treat a debilitating disease or to relieve the
pain and suffering of a seriously ill patient or terminally ill patient before prescribing
the schedule I drug. A physician who prescribes a schedule shall obtain the written
opinion of a second physician that the prescribing of a schedule I drug is appropriate
to treat a debilitating disease or to relieve he pain and suffering of a seriously ill
patient or terminally ill patient. The written opinion of the second physician shall be
kept in the patient's official medical file. Before prescribing, the physician shall
receive the written consent of the patient.
C. The allopathic board of medical examiners or board of osteopathic examiners in
medicine and surgery may investigate any physician who fails to comply with the
provisions of this section and may discipline the physician.
See ARiz. REV. STAT. § 13-3412.01 (1996)
250. See id.
251. Id.
NORTH DAKOTA LAW REVIEW [VOL. 75:555
not only marijuana, but also other Schedule I substances such as heroin
and LSD.252 Finally, five more states passed medicinal marijuana laws in
1998.253
Upon passage of these laws, the federal government publicly de-
clared its opposition and announced a federal strategy that would place
repercussions on physicians who prescribe marijuana. 254 By doing so,
the federal government sought to avoid the appearance that it approves
of illegal or addictive drug use, which might send the "wrong message"
to citizens, especially youth. 255 This stance means that state laws
allowing the medicinal use of marijuana may not last, since they are
252. See id
253. NORML (last visited Feb. 2, 1999) <http://www.norml.org/news/archives/98-1 1-04.html>.
The Alaska and Oregon proposals allow patients to possess up to one ounce of marijuana legally or to
cultivate three mature plants for medical use. See id. Colorado's Proposal 19 exempts individuals
suffering from debilitating illnesses from Colorado's criminal laws regarding possession and use of
marijuana provided that they: 1) are in lawful possession of a state registry identification card; 2)
possess no more that two ounces of marijuana or no more than six growing plants; 3) are not
endangering the health or well-being of any person; and 4) are not using marijuana in plain view or in
a place open to the general public. See Vote: Referred Proposals, DEv. POST, Oct. 25, 1998, at 21.
The District of Columbia amended the Uniform Controlled Substance Act of 1981 to allow medical
patients to use marijuana for medicinal purposes upon the recommendation of a licensed physician.
See D.C. CODE ANN. § 33-501 (1981) (amended 1998). Finally, Washington passed Initiative 692,
which allows patients to possess up to a sixty day supply of marijuana for medical use. NORML (last
visited Feb. 2, 1999) <httpJ/www.norml.org/news/archives/98-11-04.html>.
254. See McGuire. supra note 47, at 94. The Clinton Administration announced that physicians
who prescribe marijuana may face repercussions from the federal government. See McGuire, supra
note 47. at 94. Possible penalties include exclusion from federally funded Medicaid and Medicare
programs, federal criminal charges, and having their DEA certification, which grants the authority to
prescribe controlled substances, revoked. See McGuire, supra note 47, at 94. The focus of the plan is
strict enforcement of federal law. See McGuire, supra note 47, at 95 However, the plan does little or
nothing to diminish the policy conflicts. Instead, physicians are able to get around the federal plan by
giving patients a written or oral recommendation for marijuana use rather that a prescription. See
McGuire, supra note 47, at 94. No federal law is violated by recommending marijuana because the
First Amendment protects a physician's right to express an opinion. See McGuire, supra note 47, at
94.
255. See McGuire, supra note 47, at 93.
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subject to federal preemption. 256
3. Federal Preemption
The Supremacy Clause of the United States Constitution makes the
Constitution and federal law the supreme law of the land.257 It
"invalidates state laws that interfere with or are contrary to federal
law." 258 The state, however, has jurisdiction over all persons and things
within its territorial limits, 259 and it is not only the right, but the duty of a
state to advance the safety, happiness, prosperity and general welfare of
its people through its police powers. 260 The police powers of a state are
not confined to the suppression of what is offensive, disorderly or
unsanitary, but extend to acting for the greatest welfare of the state. 261
The states thus have the ability to use their police powers to protect the
256. See Dominica Minore Basset, Legislative Review, Medical Use and Prescription of Sched-
ule I Drugs in Arizona: Is the Battle Moot? 30 ARIz. ST. L. J. 441, 450 (1997). Currently pending in
the House of Commerce Subcommittee on Health and Environment is H.R. 1782, The Medical Use of
Marijuana Act. H.R. 1782, 105th Cong. (1997). The Act states that:
[N]o provision of the Controlled Substance Act... shall prohibit or otherwise restrict:
1 ) the prescription or recommendation of marijuana by a physician for medical use,
2) an individual from obtaining and using marijuana from a prescription or recom-
mendation of marijuana by a physician for medical use by such individual, or
3) a pharmacy from obtaining and holding marijuana for the prescription of mari-
juana by a physician for medical use under applicable state law in a state in which
marijuana may be prescribed or recommended by a physician for medical use
under applicable state law.
H.R. 1782, 105th Cong. (1997).
The Act was introduced by Representative Barry Frank, a Democrat from Massachusetts, on
June 4, 1997. The Medical Use of Marijuana Act (last visited Nov. 11, 1998) <http://www.nornl.org/
medicalpets98.html>. The bill would reschedule marijuana from Schedule I to Schedule II and elimi-
nate federal restrictions that currently interfere with an individuals state's decision to permit the medi-
cal use of marijuana. See id. The effect of this law would permit the individual states to decide for
themselves whether to permit medical use of marijuana. See id. The bill is not a mandate from Wash-
ington and would not require any state to change its current laws. See id. The legislation would set
aside the effect of the CSA and would make fully operative the laws in those states which permit the
medical use of marijuana without preemptive and controlling restrictions currently in place. See id.
257. See U.S. CoNST. art. VI, cl.2. The clause states:
This Constitution, and the Laws of the United States which shall be made in pursuance
thereof; and all treaties made, or which shall be made, under the authority of the United
States, shall be the supreme law of the land; and the judges in every state shall be bound
thereby, any thing in the Constitution or laws of any state to the contrary notwithstanding.
See id.
258. See Bassett, supra note 256, at 450.
259. See First Nat'l Ben. Soc'y v. Garrison Ins. Comm'r of Cal., 58 F. Supp. 972, 980 (S.D. Cal.
1945). See also Rice v. Santa Fe Elevator Corp., 331 U.S. 218 (1989) (stating that the state may super-
sede federal laws as long as the state does not interfere with the clear and manifest purpose of
Congress).
260. See First Nat'l, 58 F. Supp. at 980. For example, the states that have legalized marijuana are
using their police powers to protect, the safety, happiness, prosperity and general welfare of their
people who are suffering from debilitating illness by allowing marijuana use for medical purposes.
See id.
261. See id. at 981.
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health and safety of their citizens without being "superseded by a
federal law" unless such was the clear and manifest purpose of
Congress. 262
In contrast to the authority of the state, which is limited by its bor-
ders, Congress has express power to "regulate Commerce with foreign
Nations, and among the several states, and with the Indian Tribes." 263
Thus, Congress has the power to occupy, by legislation, the whole field
of interstate commerce. 264 Accordingly, it is only the direct interference
with interstate commerce that brings an issue within the exclusive domain
of federal legislation. 265 This has had repercussions for the regulation of
marijuana.
In United States v. Visman,266 a federal appeals court construed the
Controls Act of 1970267 as evidence that Congress's determination that
1) marijuana poses some dangers or risks to the health and welfare of
Americans; 2) the local cultivation, distribution and possession of mari-
juana has an impact on increasing interstate commerce of marijuana; and
3) federal control of both interstate and intrastate commerce 268 is war-
ranted as a necessary component of effective regulation of the interstate
use of marijuana. 269 Thus, because Congress may regulate not only
interstate commerce but also intrastate activities that have an effect upon
interstate commerce, Congress may enforce the prohibition of mari-
juana.270 In other words, because state marijuana legalization would
directly interfere with Congress's right to control drug trafficking,
federal legislation would supersede such state decisions. 271 Therefore, it
is unclear how long those states that have legalized the drug will be able
262. See Bassett, supra note 256, at 450 (quoting Gibbons v. Ogden, 22 U.S. (9 Wheat.) 1, 211
(1824)). See also Hill v. State, 325 U.S. 538 (1945) (stating that the states may protect local interests
so long as Congress has not implemented local regulation either by a regulation of its own or by an
unmistakable indication that there is to be no regulation at all).
263. See U.S. CoNsT. art. I, § 8, cl. 3.
264. See Champion v. Ames, 188 U.S. 321, 358 (1903). Interstate commerce is the traffic, inter-
course, or commercial trading or the transportation of persons or property between or among the
several states. See BLACK'S LAW DICrIoNARY 819 (6th ed. 1990).
265. See Field v. Barbar Asphalt Paving Co., 194 U.S. 618, 623 (1904).
266. 919 F.2d 1390 (9th Cir. 1990).
267. See Controls Act of 1970, 18 U.S.C. § 801 (1994).
268. Intrastate commerce is commerce within the state. See BLACK'S LAW DICTIoNARY 822 (6th
ed. 1990).
269. See United States v. Visman, 919 F.2d 1390, 1392 (9th Cir. 1990).
270. See Crites-Leoni, supra note 7, at 299 (citing Wickard v. Filburn, 317 U.S. 111, 125 (1942)).
271. See Field v. Barbar Asphalt Paving Co., 194 U.S. 618, 623 (1904).
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to continue enforcing their laws without subjecting their citizens to
federal prosecution and sanctions. 272
VI. CONCLUSION
The legalization of marijuana for medical use is a controversial
debate that will likely continue for years to come. 273 The effectiveness
of the drug on terminally or seriously ill patients is promising, but the
risks involved are overpowering. 274 There are risks not only to the pa-
tients, but also to the federal government's anti-drug policies. 275 Legal-
izing the drug for medical use would make it more accessible not only to
patients, but to recreational users as well. 276
The best way to allow needy patients the chance to reap the benefits
of the drug is to allow the courts to consider the "medical necessity" of
marijuana on a case-by-case basis.277 This can be done by federal
legislation giving courts the freedom to make decisions based on facts
presented by each case.278 Until more conclusive research can be done
on the effects of marijuana, total legalization for medical use is
premature. 279
Deborah Gamer
272. See id. So far the federal government has not done much to challenge the state laws. See
McGuire, supra note 47 at 92-93. The government is concerned that if they do, the court system will
be flooded. See McGuire, supra note 47, at 92-93. Instead, the federal government has opted to place
repercussions upon the physicians prescribing the drug and is strongly discouraging states from passing
legalizing laws. See McGuire, supra note 47, at 92-93.
273. See McGuire, supra note 47, at 73.
274. See Crites-Leoni, supra note 7, at 284-85.
275. See Crites-Leoni, supra note 7, at 284-85.
276. See Crites-Leoni, supra note 7, at 304.
277. See Grey, supra note 12, at 272-73.
278. See State v. Tate, 505 A.2d 941, 944 (N.J. 1986).
279. See Crites-Leoni, supra note 7, at 284-85.
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